177 related articles for article (PubMed ID: 34572265)
41. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
42. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
[TBL] [Abstract][Full Text] [Related]
43. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
44. Identification of miR-30c-5p microRNA in Serum as a Candidate Biomarker to Diagnose Endometriosis.
Chico-Sordo L; Ruiz-Martínez T; Toribio M; González-Martín R; Spagnolo E; Domínguez F; Hernández A; García-Velasco JA
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339132
[TBL] [Abstract][Full Text] [Related]
45. MiR-30c-5p mediates inflammatory responses and promotes microglia survival by targeting eIF2α during Cryptococcus neoformans infection.
Jin Y; Yao G; Wang Y; Teng L; Wang Y; Chen H; Gao R; Lin W; Wang Z; Chen J
Microb Pathog; 2020 Apr; 141():103959. PubMed ID: 31958475
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-182-5p Modulates Oral Squamous Cell Carcinoma Migration and Invasion Via Targeting MTSS1 Gene.
Guo Y; Qiao X; Zhu L; Song R
Pathol Oncol Res; 2020 Apr; 26(2):1007-1013. PubMed ID: 30949866
[TBL] [Abstract][Full Text] [Related]
47. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
Chen W; Yao G; Zhou K
J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
[TBL] [Abstract][Full Text] [Related]
48. Salivary microRNAs identified by small RNA sequencing as potential predictors of response to intensity-modulated radiotherapy in head and neck cancer patients.
Ahmad P; Slavik M; Trachtova K; Gablo NA; Kazda T; Gurin D; Smilek P; Horakova Z; Gal B; Hermanova M; Slampa P; Sana J; Slaby O
Cell Oncol (Dordr); 2020 Jun; 43(3):505-511. PubMed ID: 32266559
[TBL] [Abstract][Full Text] [Related]
49. RP11-874J12.4 promotes oral squamous cell carcinoma tumorigenesis via the miR-19a-5p/EBF1 axis.
Liu GM; Lu TC; Sun ML; Ji X; Zhao YA; Jia WY; Luo YG
J Oral Pathol Med; 2020 Aug; 49(7):645-654. PubMed ID: 32004389
[TBL] [Abstract][Full Text] [Related]
50. miR-193b and miR-30c-1
Kordaß T; Weber CEM; Eisel D; Pane AA; Osen W; Eichmüller SB
Oncotarget; 2018 Aug; 9(65):32507-32522. PubMed ID: 30197759
[TBL] [Abstract][Full Text] [Related]
51. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
Niu X; Yang B; Liu F; Fang Q
Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
[TBL] [Abstract][Full Text] [Related]
52. The expression of miR-125b-5p is increased in the serum of patients with chronic hepatitis B infection and inhibits the detection of hepatitis B virus surface antigen.
Ninomiya M; Kondo Y; Kimura O; Funayama R; Nagashima T; Kogure T; Morosawa T; Tanaka Y; Nakayama K; Shimosegawa T
J Viral Hepat; 2016 May; 23(5):330-9. PubMed ID: 26924666
[TBL] [Abstract][Full Text] [Related]
53. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
54. Knockdown of NEAT1 mitigates ox-LDL-induced injury in human umbilical vein endothelial cells via miR-30c-5p/TCF7 axis.
Guo JT; Wang L; Yu HB
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9633-9644. PubMed ID: 33015807
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
[TBL] [Abstract][Full Text] [Related]
57. Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease.
Divi SN; Markova DZ; Fang T; Guzek R; Kurd MF; Rihn JA; Hilibrand AS; Anderson DG; Vaccaro AR; Schroeder GD; Kepler CK
Spine (Phila Pa 1976); 2020 May; 45(9):E499-E507. PubMed ID: 31770330
[TBL] [Abstract][Full Text] [Related]
58. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10.
Chen F; Xu B; Li J; Yang X; Gu J; Yao X; Sun X
J Exp Clin Cancer Res; 2021 Jan; 40(1):38. PubMed ID: 33485367
[TBL] [Abstract][Full Text] [Related]
59. miR-31-5p Is a Potential Circulating Biomarker and Therapeutic Target for Oral Cancer.
Lu Z; He Q; Liang J; Li W; Su Q; Chen Z; Wan Q; Zhou X; Cao L; Sun J; Wu Y; Liu L; Wu X; Hou J; Lian K; Wang A
Mol Ther Nucleic Acids; 2019 Jun; 16():471-480. PubMed ID: 31051332
[TBL] [Abstract][Full Text] [Related]
60. Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey.
Lin Y; Miao Z; Zhang X; Wei X; Hou J; Huang Y; Shen B
Front Genet; 2020; 11():596826. PubMed ID: 33519899
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
